Scientists Are Killing Cancer With Help From Herpes Virus

Herpes Virus is killing cancer cells

The Food and Drug Administration has approved a new virus-based therapy that uses the talimogene laherparepvec (T-VEC) virus, a genetically engineered herpes simplex strain, to fight off cancer cells.

While scientists still have no idea how to eradicate cancer, new treats are helping put a stop to abnormal cell growth and in some cases cure certain types of cancer.

This new process involves infecting the patient’s body with a variation of the herpes virus that won’t cause herpes as we think of it. Instead, the virus attacks tumor cells and kill them.

The newly approved virus treatment is effective in fighting against advanced melanoma, initiating “cellular carnage.” The virus also carries a protein called GM-CSF that triggers the immune system that jumps in as the virus destroys cancer cells.

Clinical trials have shown that the virus was able to shrink down tumors and extend patient survival by 4.4 months. Once combined with other forms of treatment, the drug could prove to be even more successful.

Written by Peter Mondrose

Peter Mondrose

Peter Mondrose is the Editor-In-Chief at BusinessPundit. He received his degree in Economics in 1998 and a second degree in Journalism in 2004. He has served as a financial adviser, market trader, and freelance journalist for the last 11 years. When he's not investigating market conditions and reporting on workplace news, he can be found traveling with his wife, dog, and laptop. He can be reached at PeterMondrose@BusinessPundit.com or (929) 265-0240.